Basit öğe kaydını göster

dc.contributor.authorKacmaz, B
dc.contributor.authorAksoy, A
dc.date.accessioned2020-06-25T17:40:35Z
dc.date.available2020-06-25T17:40:35Z
dc.date.issued2005
dc.identifier.issn0924-8579
dc.identifier.issn1872-7913
dc.identifier.urihttps://doi.org/10.1016/j.ijantimicag.2005.02.020
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3495
dc.descriptionAksoy, Abdurrahman/0000-0001-9486-312Xen_US
dc.descriptionWOS: 000230227100013en_US
dc.descriptionPubMed: 15908184en_US
dc.description.abstractSusceptibility to ampicillin, penicillin, vancomycin and teicoplanin, high-level resistance to aminoglycosides (gentamicin and streptomycin) and beta-lactamase production were investigated among 264 consecutive clinical enterococcal isolates in Turkey. Disc diffusion test was used to detect resistance to ampicillin, penicillin, vancomycin and teicoplanin. High-level resistance to aminoglycosides was determined both by standard agar screening and by disc diffusion methods. The values of minimum inhibitory concentration (MIC) of each isolate for ampicillin, vancomycin and teicoplanin were determined by the microbroth dilution technique. The isolates were found to consist of Enterococcus faecalis (78%), Enterococcus faecium (9%) and Enterococcus spp. (12%). In all strains, the penicillin and ampicillin resistance ratios were 27% and 26%, respectively. Enterococcus faecalis was more susceptible to penicillin and ampicillin than the other strains. None of the strains were resistant to glycopeptides. High-level aminoglycoside resistance was found in 16% E. faecalis and 88% E. faecium for gentamicin, and 35% and 44%, respectively, for streptomycin. There were no differences between the two methods used to determine the aminoglycoside resistance rates in the enterococcal isolates. No beta-lactamase-producing isolates were detected in either species. In conclusion, to determine the resistance of enterococci to the penicillin group of drugs by the disc diffusion method, both penicillin and ampicillin discs should be evaluated. In serious enterococcal infections, before starting combined therapy, high-level aminoglycoside resistance should be investigated. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.ijantimicag.2005.02.020en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectenterococcien_US
dc.subjectantibiotic resistanceen_US
dc.subjecthigh-level aminoglycoside resistanceen_US
dc.subjectTurkeyen_US
dc.titleAntimicrobial resistance of enterococci in Turkeyen_US
dc.typearticleen_US
dc.contributor.departmentKırıkkale Üniversitesien_US
dc.identifier.volume25en_US
dc.identifier.issue6en_US
dc.identifier.startpage535en_US
dc.identifier.endpage538en_US
dc.relation.journalInternational Journal Of Antimicrobial Agentsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster